The new edition of our digital magazine is out now – you can read it online for free. Here are some of the highlights from this month’s edition.
According to GlobalData’s Market Size and Growth database, the overall patient monitoring market was valued at around $18bn in 2023 and is forecast to reach a valuation of almost $24bn by 2033.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
In this month’s cover story we put remote patient monitoring for chronic conditions into the spotlight.
We also explore how artificial intelligence (AI) is being used to personalise IVF treatment. Research shows that AI has the potential to influence the optimisation and personalisation of key steps in IVF, including cycle monitoring, induction of oocyte (egg) maturation, and selection of the most competent gametes and embryos, to improve the overall efficacy and safety of ART.
Elsewhere in this issue, we examine why the paediatric healthcare segment is furious over the US Food and Drug Administration’s (FDA) final ruling classifying laboratory-developed tests (LDT) as medical devices.
All this and the latest medical device industry news, comment, and analysis from GlobalData.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIf you like our magazine, sign up to have each issue delivered to your inbox.
